Hepatitis B immune globulin for preventing hepatitis B recurrence after liver transplantation

We aim to assess the benefits and harms of HBIg after liver transplantation in HBV-infected patients.

We will try to find the minimal effective dose and time of the HBIg treatment in order to reduce the adverse effects as well as cost of the treatment.

This is a protocol.

You may also be interested in:

Hepatitis B immunoglobulin (HBIG) during pregnancy for the prevention of mother-to-child transmission of hepatitis B virus (HBV)
Hepatitis B vaccine, hepatitis B immunoglobulin, and hepatitis B vaccine plus immunoglobulin prevent perinatal transmission of hepatitis B
Vaccines for preventing hepatitis B in healthcare workers (an updated protocol)
Tiopronin for chronic hepatitis B
Medical interventions to prevent early graft rejection after liver transplantation

Health topics:

Gastroenterology & hepatology > Liver disorders > Transplantation

Gastroenterology & hepatology > Liver disorders > Hepatitis B

Infectious disease > Liver infections > Hepatitis B

Don't show again

What role do you identify with the most?

Patient or care giver

Health practitioner

Researcher

Policy Maker

We are collecting information on visitors to our website to ensure Cochrane resources meet the needs of our users. Your data will be anonymised for processing, will be stored securely, and will not be shared with any third parties.